AXE archer materials limited

0.00%

23.0¢

What is happening, page-3600

First 3600 Last

Share
Profile

Follow
Wedgeman7

2,078 Posts.

705

13/08/24

11:02

Post #: 75181819
Share

Originally posted by NoImSpartacus: ↑

This thing is a lemon. I dont think they ever had a well thought out plan for commercialization. But AXE has been lucky. They have a very compliant retail shareholder cohort that has always put a positive spin on whatever happened or more accurately didn't happen. So even though, in the last 3 yrs, the SP has fallen over 90%, with only brief moments of recovery before continuing its relentless downward slide, we said nothing as the slide continued. It was only after the CEO bailed that we started to hear some rumblings but frankly Im beginning to think it was too late. I was hoping they had something in the pipeline that would give us reason to believe that some significant progress had been made towards commercializing at least the biochip but now I'm beginning to think that they havnt done much in that regard at all.

If you dont like what Im saying block me but Im not going to shut up. We watched this thing drop by 90% while the faithful, convinced they would be Billionaires within a few short months shouted down anyone who might have suggested that there was something seriously wrong with the AXE strategy and where did that get us? That's my opinion! DYOR

Expand

I can’t agree more. My first few posts here were attacked so I didn’t invest and just kept it on my watch list. Now I’m looking forward to the price falling below 18c or even below 10c and I might pick up a few on the off chance the team can pull a rabbit out of the hat.

AXE Price at posting: 25.5¢ Sentiment: None Disclosure: Not Held
1 Upvote

1 Great analysis

Reply

Top Stories

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 3600 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 23.0¢		Change 0.000(0.00%)		Mkt cap ! $58.61M

Open	High	Low	Value	Volume
22.5¢	24.0¢	22.5¢	$89.25K	387.4K

Buyers (Bids)

No.	Vol.	Price($)
4	104441	23.0¢

Sellers (Offers)

Price($)	Vol.	No.
23.5¢	56023	2

View Market Depth

No.	Vol.	Price($)
4	104441	0.230
9	184295	0.225
13	248602	0.220
7	58193	0.215
8	164657	0.210

Price($)	Vol.	No.
0.235	56023	2
0.240	101099	4
0.245	7000	1
0.250	76000	3
0.255	129000	3

Last trade - 16.10pm 27/06/2025 (20 minute delay)

AXE (ASX) Chart

What is happening, page-3600

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

What is happening, page-3600

Top Stories

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News